— Showcasing the Potential of Japan’s Healthcare DX to India and the World —

CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”) is pleased to announce that CEO Masakazu Nakajima spoke at the “22nd CII Annual Health Summit 2025,” organized by the Confederation of Indian Industry (CII) and held on November 11, 2025, in New Delhi, India.

The Summit is one of India’s premier international healthcare conferences, bringing together key stakeholders from the Ministry of Health and Family Welfare (MOHFW), government authorities, healthcare providers, insurers, medical device manufacturers, pharmaceutical companies, and digital health innovators.
Under the theme “Viksit Bharat @2047,” this year’s event focused on policy dialogue and innovation, exploring the future of healthcare from multiple perspectives.

Showcasing Japanese Healthcare Innovations at MEJ’s “Japan Connect” Program

The Summit also featured the “2nd MEJ-India Seminar: Showcasing Japan Healthcare Innovations,” officially hosted by Medical Excellence JAPAN (MEJ). The seminar brought together approximately 60 participants from Japan, and more than 30 Japanese companies from the medical device, pharmaceutical, and digital health sectors were introduced—highlighting the growing momentum for Japan–India collaboration in healthcare.

During this program, Nakajima introduced CarbGeM’s latest AI-driven solutions, including the company’s cloud-based AI image analysis platform CarbConnect® and microbial morphology estimation AI software BiTTE®, covering:

• AI-powered infectious disease diagnostic support
• Process DX for research and biomanufacturing workflows
• AI applications addressing global AMR (Antimicrobial Resistance) challenges

He emphasized the potential of Japan-origin healthcare AI to improve medical access, enhance quality of care, and support evidence-based decision-making across clinical and industrial fields.

Overview of the CII Annual Health Summit 2025

• Event Name: 22nd CII Annual Health Summit 2025
• Organizer: Confederation of Indian Industry (CII)
• Date: November 11, 2025
• Location: New Delhi, India
• Key Themes:
  ◦ Japan Connect (Japan–India healthcare collaboration)

  ◦ Digital health, AI, and health data utilization

  ◦ Healthcare access, insurance reform, and regulatory innovation

  ◦ Medical Value Travel (MVT)

  ◦ Aging, climate-related health risks, and emerging infectious diseases

  ◦ Policy roundtables with government ministries
• Participants: Government officials, healthcare institutions, insurers, medical device and pharmaceutical companies, digital health startups, investors, researchers, and more
• Website: https://cam.mycii.in/OR/EventDetailOR.html?id=E000071624

About CarbGeM Inc.

CarbGeM is a technology company driving innovation across the life sciences through advanced solutions, including regulatory-approved Software as a Medical Device (SaMD). Our AI and digital platforms support diagnostic workflows, streamline research processes, and promote standardized and automated quality control across clinical, research, and industrial settings.

By addressing social challenges—such as shortages of skilled personnel and regional disparities—we help enable fast and accurate decision-making in medical and industrial environments.
Our solutions span research-use AI, municipal and industrial DX, and evidence-based decision support leveraging scientific and data-driven insights.

CarbGeM has received numerous awards, including the Tokyo Social Innovation Tech Award 2024, and actively advances open innovation through collaboration with industry, government, and academia to build the future of healthcare, research, and local communities.

Website: https://carbgem.com/en/